Coerente Capital Management Has $1.86 Million Stake in Procter & Gamble Company (The) $PG

Coerente Capital Management trimmed its holdings in Procter & Gamble Company (The) (NYSE:PG) by 23.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,681 shares of the company’s stock after selling 3,678 shares during the period. Procter & Gamble accounts for 0.3% of Coerente Capital Management’s holdings, making the stock its 25th largest position. Coerente Capital Management’s holdings in Procter & Gamble were worth $1,861,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in PG. Stableford Capital II LLC grew its stake in shares of Procter & Gamble by 1.1% in the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company’s stock worth $993,000 after purchasing an additional 61 shares during the last quarter. Bernard Wealth Management Corp. boosted its position in Procter & Gamble by 20.2% during the first quarter. Bernard Wealth Management Corp. now owns 375 shares of the company’s stock valued at $64,000 after acquiring an additional 63 shares during the last quarter. B & T Capital Management DBA Alpha Capital Management boosted its position in Procter & Gamble by 2.3% during the first quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company’s stock valued at $476,000 after acquiring an additional 63 shares during the last quarter. Private Management Group Inc. boosted its position in Procter & Gamble by 4.8% during the first quarter. Private Management Group Inc. now owns 1,384 shares of the company’s stock valued at $236,000 after acquiring an additional 64 shares during the last quarter. Finally, Lantz Financial LLC boosted its position in Procter & Gamble by 1.2% during the second quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock valued at $834,000 after acquiring an additional 64 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CFO Andre Schulten sold 11,638 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the transaction, the chief financial officer directly owned 52,642 shares of the company’s stock, valued at $8,279,007.34. This represents a 18.11% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jon R. Moeller sold 40,119 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the transaction, the chief executive officer directly owned 319,375 shares of the company’s stock, valued at $50,228,106.25. This represents a 11.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have commented on PG shares. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Wells Fargo & Company cut their price objective on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. BNP Paribas Exane lowered their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Barclays lowered their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Finally, BNP Paribas restated an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $172.58.

Procter & Gamble Trading Down 0.1%

NYSE:PG opened at $150.53 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The firm has a market cap of $352.31 billion, a price-to-earnings ratio of 23.12, a price-to-earnings-growth ratio of 4.00 and a beta of 0.36. Procter & Gamble Company has a 52 week low of $149.58 and a 52 week high of $180.43. The firm has a 50-day moving average price of $155.26 and a two-hundred day moving average price of $159.62.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.